In a market where growth is hard to come by investors have demonstrated they are willing to pay big multiples for businesses that stand out from the crowd. Nearly all the stocks in this episode are currently trading at 30x trailing earnings. They also give investors exposure to themes and sectors with attractive outlooks - such as healthcare and telecommunications. However the question remains, are they worth the price or too expensive? To get some expert views Matthew Kidman from Centennial Funds hosts Ben Clark from TMS Capital and Ben Rundle from NAOS Asset Management in the latest episode of Buy Hold Sell. The stocks discussed include Sirtex, iSentia, Vocus, A2 Milk, and Mayne Pharma.
General Advice Warning:
The site may contain, or may be linked to, investment reports, options, estimates, recommendations and other information (Information). However, such information comprises general securities advice only and has not been prepared taking into account the particular investment objectives, financial situation and needs of any particular person. You should carefully assess whether such information is appropriate in light of your individual circumstances before acting on it. TMS Capital Pty Ltd strongly recommends that you seek independent advice from a qualified professional before acting on any of the information contained on this Site or any other website on the Internet.